Reply to: "Risk factors and screening intervals are crucial for evaluating the cost effectiveness of abbreviated MRI in HCC screening"

J Hepatol. 2021 Nov;75(5):1259-1260. doi: 10.1016/j.jhep.2021.08.002. Epub 2021 Aug 23.

Authors

Pankaj Gupta¹, Vishal Sharma², Naveen Kalra³

Affiliations

¹ Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Electronic address: Pankajgupta959@gmail.com.
² Gastroenterology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
³ Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

PMID: 34437909
DOI: 10.1016/j.jhep.2021.08.002

No abstract available

Keywords: Liver Cancer; Risk Assessment; Surveillance.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular* / diagnostic imaging
Carcinoma, Hepatocellular* / epidemiology
Cost-Benefit Analysis
Humans
Liver Neoplasms* / diagnostic imaging
Liver Neoplasms* / epidemiology
Magnetic Resonance Imaging
Mass Screening
Risk Factors